![]() Inclusion criteria: male aged 18 to 55 years meeting Food and Drug Administration requirements for methadone maintenance treatment had been receiving methadone for at least 2 weeks but not more than 6 months during their current treatment episode subgroup met DSM‐III criteria for AsPD (obtained via MPI and SADS)Įxclusion criteria: psychosis persistent or clinically significant organic brain syndrome serious medical, legal or personal problems that would require movement from local area within 1 yearĮthnicity: (for whole sample a) black (62%) white (38%)īaseline characteristics: (for whole sample a) lifetime major depressive disorder (35%) lifetime anxiety disorder, any (20%) lifetime alcoholism (19%) antisocial personality disorder (45%) ![]() Setting: outpatient single site urban USA (Philadelphia) ![]() Number randomised: 50 with AsPD (breakdown by treatment group not available a) Unit of allocation: individual participant Participants: methadone‐maintained male outpatients with AsPD and opioid dependence aĪge: (for whole sample a) mean = 29 years (SD = 6) ![]() Design: parallel randomised controlled trial ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |